Advanced Renal Cell Carcinoma Active Not Recruiting Phase 2 Trials for Trebananib (DB12056)

Also known as: Advanced Renal cell carcinoma

IndicationStatusPhase
DBCOND0032596 (Advanced Renal Cell Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs